Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized studyDenise Hilfiker‐Kleiner, Johann Bauersachs, Uwe Kühl et al.|European Heart Journal|2017Cited by 334
Prognostic Implication of Right Ventricular Involvement in Peripartum Cardiomyopathy: A Cardiovascular Magnetic Resonance StudyJohann Bauersachs, Philipp Röntgen, Jens Vogel‐Claussen et al.|ESC Heart Failure|2015Cited by 97
Rationale and Design of the DIGIT-HF Trial (DIGitoxin to Improve Outcomes in Patients with Advanced Chronic Heart Failure): A Randomized, Double-Blind, Placebo-Controlled StudyUdo Bavendiek, Johann Bauersachs, Dominik Berliner et al.|European Journal of Heart Failure|2019Cited by 82
Long-Term Follow-up in Peripartum Cardiomyopathy Patients with Contemporary Treatment: Low Mortality, High Cardiac Recovery, but Significant Cardiovascular Co-MorbiditiesValeska Abou Moulig, Johann Bauersachs, Tobias J. Pfeffer et al.|European Journal of Heart Failure|2019Cited by 81
Digitoxin in Patients with Heart Failure and Reduced Ejection FractionUdo Bavendiek, Johann Bauersachs, Anika Großhennig et al.|New England Journal of Medicine|2025Cited by 65